Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLT-ONE pilot adjuvant chemotherapy study in elderly early breast cancer
2010-024067-41Phase 2Completed
- Sponsor
- Fondazione per le Attività di Ricerca in Oncologia
- Start
- Dec 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxorubicin, cyclophosphamide and paclitaxel in breast cancer, sponsored by Fondazione per le Attività di Ricerca in Oncologia. Primary endpoint: Safety. Started Dec 2011; status: completed.
02
Drugs
doxorubicincyclophosphamidepaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-024067-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024067-41.